D-0019-2023 Class I Terminated
FDA drug recall D-0019-2023 was initiated by Golden State Medical Supply Inc. on Sep 29, 2022 and is designated Class I. Reason for recall: Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets The recall status is terminated (terminated Mar 20, 2025). Affected quantity: 2,584 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 2, 2022
- Initiation Date
- Sep 29, 2022
- Termination Date
- Mar 20, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,584 Bottles
Product description
Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-10
Reason for recall
Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets
Distribution pattern
USA Nationwide
Code information
Lot #: GS046745, Exp 12/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0019-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026